Key Takeaways Thermo Fisher Scientific shares jumped Thursday after the medical device maker reported better-than-expected ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve ...

Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Abbott Laboratories on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated ...

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...

With a year of college eligibility remaining, Brock Vandagriff decided to walk away from football. The former Kentucky ...

Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices.

The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8 ...

Rochester, is the chief author of a bill that would extend a sales tax exemption to a broader pool of medical devices and ...

Abbott Laboratories (ABT) reported weaker-than-expected fourth quarter sales due to weakness in its nutrition and diagnostics ...